Your session is about to expire
← Back to Search
Depression and Adherence in Head and Neck Cancer
N/A
Waitlist Available
Led By Eileen H. Shinn, PhD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
Primary Objectives: * Develop and pilot test an innovative intervention to determine its feasibility and acceptability to patients. Recruitment rate, patient satisfaction, attendance, questionnaire completion rates and the reliability and validity of the questionnaires will be assessed. * Conduct preliminary analyses on the efficacy of the intervention in improving patients' depression. Evaluate whether depression levels in patients receiving the intervention decreases, and whether the decrease is greater among those who complete more sessions. * Test the relationship between patients' depression levels and adherence to swallowing rehabilitation and to dental preventive maintenance regimens.
Eligible Conditions
- Head and Neck Cancers
- Oropharyngeal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Questionnaire + Depression InterventionExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaire
2014
Completed Phase 2
~19970
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,952 Previous Clinical Trials
41,111,786 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,071 Previous Clinical Trials
1,803,018 Total Patients Enrolled
Eileen H. Shinn, PhDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
409 Total Patients Enrolled